Press release
Phenobarbital Market Future Trends and Scope Analysis Report
According to the latest research by InsightAce Analytic, the Global Phenobarbital Market is valued at US$ 1.48 Bn in 2022, and it is expected to reach US$ 2.20 Bn by 2031, with a CAGR of 4.6% during a forecast period of 2023-2031.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2049
The sedative and anti-seizure effects of phenobarbital, a class C-IV control drug, are used to treat alcohol withdrawal in individuals with status epilepticus. A barbiturate drug, phenobarbital, is also referred to as phenobarbitone or phenobarb and is available under the brand names Luminal and other names. The World Health Organisation (WHO) recommends it for the management of specific forms of epilepsy in underdeveloped nations. Phenobarbital is only administered intravenously in dire circumstances.
According to studies, induration at the infusion site reduces the bioavailability of phenobarbital. It is advised to taper off the medicine because abrupt stopping can cause withdrawal symptoms in patients. According to the American Epilepsy Society's most recent recommendations, phenobarbital is often administered intravenously (15 mg/kg) to adult patients with status epilepticus. Phenobarbital has a long history of usage and is well-known for its effectiveness in the treatment of epilepsy and seizure disorders. It is regarded as a first-line treatment for several types of seizures, especially in areas with limited resources. Due to the medication's success in reducing seizures, there is a demand for it on the market.
List of Prominent Players in the Phenobarbital Market:
• Sanofi
• Pfizer Inc.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• Hikma Pharmaceuticals
• Zydus Cadila
• Lannett Company, Inc.
• Strides Pharma Science Limited
• Cipla Ltd.
• Lupin Limited
• Aurobindo Pharma Limited
• Torrent Pharmaceuticals Ltd.
• Reddy's Laboratories Ltd.
Market Dynamics:
Drivers-
An established manufacturing, distribution, and prescription infrastructure supports the accessibility of phenobarbital. Patients who require anticonvulsant therapy can easily acquire the medication because of this infrastructure, which guarantees a steady supply to hospitals and pharmacies. The market for phenobarbital is significantly driven by the prevalence of epilepsy and seizure disorders. Bns of individuals around the world suffer from epilepsy, and there is a continuing need for potent anticonvulsants. With its well-established efficacy, phenobarbital is essential in treating epilepsy, particularly in areas where the condition is more common.
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2049
Challenges:
The drug phenobarbital has a number of undesirable side effects, such as drowsiness, cognitive decline, vertigo, and behavioural abnormalities. These side effects, particularly when the medicine impairs everyday activities or cognitive function, may affect patient compliance and quality of life. Safety considerations regarding the possibility of extreme adverse events, such as infrequent but severe adverse reactions, must also be taken into account.
Regional Trends:
The North American phenobarbital market is expected to register a major market revenue share and it is projected to grow at a high CAGR in the near future. The emergence of new market participants and advancement of the paediatric formulation is anticipated to drive the market expansion in the coming years. Moreover, increasing research and development efforts aimed at improving the phenobarbital formulation's effectiveness, safety, and efficacy are the factors responsible for the market's development during the forecast period. The increasing trend of personalized treatment approaches in the country is expected to boost the market growth.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/2049
Recent Developments:
• In May 2023, Mallinckrodt, Inc. introduced a new generic variety of phenobarbital pills. The medication is offered in strengths of 15 mg, 30 mg, and 60 mg, and the majority of significant insurance policies cover it.
• In January 2023, Sun Pharma launched a brand-new, extended-release phenobarbital medication. Sun Pharma Introduces SEZABYTM (phenobarbital Sodium) for the Treatment of Neonatal Seizures in the United States.
Segmentation of Phenobarbital Market-
By Indication-
• Epilepsy
• Neonatal seizures
By Dosage Form-
• Tablets
• Injectable
• Formulations
By Distribution channel-
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
For More Information: https://www.insightaceanalytic.com/report/phenobarbital-market/2049
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Site Visit: www.insightaceanalytic.com
Email: info@insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Phenobarbital Market Future Trends and Scope Analysis Report here
News-ID: 3272928 • Views: …
More Releases from Insightace analytic
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
